Healthcare Realty Trust Incorporated (HR) — Fair Value Analysis
Base-case fair value (P50): $10.58 · Current price: $20.52 · Verdict: Overvalued
The Verdict on HR
HEALTHCARE REALTY TRUST INC CLASS (HR) is currently rated Deeply Overvalued based on our Monte Carlo simulations. With the stock trading at $20.52, our median fair value (P50) stands significantly lower at $10.58. This implies a substantial potential downside of -48.4% if HR were to converge to its intrinsic fair value derived from thousands of forward-looking scenarios. The current market price suggests a disconnect from fundamental analysis, presenting a high risk for investors holding the stock at these levels.
How HR stacks up against peers
While HR operates within a sector that is currently unrated for overall operational and financial health, our analysis indicates its individual valuation is severely stretched. The $20.52 valuation places HEALTHCARE REALTY TRUST INC CLASS at a considerable premium compared to its calculated fair value of $10.58. Given the Deeply Overvalued verdict and the -48.4% difference, HR does not appear to offer compelling value relative to its peers or its own intrinsic worth based on the probabilistic models. This suggests the market may be overestimating its future prospects or current asset values without fundamental justification.
What this means for investors
Investors in HR should exercise caution. The considerable -48.4% gap between the current trading price of $20.52 and our median fair value of $10.58 points to a challenging risk/reward profile. Our unrated quality tier suggests that HR's operational and financial health against its sector peers isn't a mitigating factor for the valuation disparity. While a bull case scenario is always possible, the current valuation, according to our FairCurve methodology, suggests significant downside potential. To fully understand the range of potential outcomes, including the bear and bull case distributions and the probability of upside, sign up for a free FairCurve account.
Frequently Asked Questions
Is HR overvalued or undervalued right now?
HR is currently deeply overvalued. Its current price of $20.52 is significantly higher than its median fair value (P50) of $10.58.
What is the bear case and bull case for HR?
The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate HR's fair value?
FairCurve calculates HR's fair value through sophisticated Monte Carlo simulations, running thousands of forward scenarios to determine a probabilistic range of intrinsic values.
How can I track HR's fair value as it changes?
You can add HR to your free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new financial fundamentals are released.